Targeted sequencing on the ovarian cancer tissue (tumor cell content 30%) applying the Tumor-Mutational Burden (TMB)-Panel revealed an additional somatic likely pathogenic variant in EPHB1 and a pathogenic variant in ATR. Abbr.: AA = amino acid; chr. Here, ATR is linked to ovarian cancer.